Yi W - Search Results

1

Bioengineered miR-328-3p modulates GLUT1-mediated glucose uptake and metabolism to exert synergistic antiproliferative effects with chemotherapeutics.

Yi W, Tu MJ, Liu Z, Zhang C, Batra N, Yu AX, Yu AM. Yi W, et al. Acta Pharm Sin B. 2020 Jan;10(1):159-170. doi: 10.1016/j.apsb.2019.11.001. Epub 2019 Nov 7. Acta Pharm Sin B. 2020. PMID: 31993313 Free PMC article.

2

Downregulation of IDH2 exacerbates the malignant progression of osteosarcoma cells via increased NF-κB and MMP-9 activation.

Yi WR, Li ZH, Qi BW, Ernest ME, Hu X, Yu AX. Yi WR, et al. Oncol Rep. 2016 Apr;35(4):2277-85. doi: 10.3892/or.2016.4553. Epub 2016 Jan 13. Oncol Rep. 2016. PMID: 26782630

3

The iron chelator Dp44mT suppresses osteosarcoma's proliferation, invasion and migration: in vitro and in vivo.

Li P, Zheng X, Shou K, Niu Y, Jian C, Zhao Y, Yi W, Hu X, Yu A. Li P, et al. Among authors: yi w. Am J Transl Res. 2016 Dec 15;8(12):5370-5385. eCollection 2016. Am J Transl Res. 2016. PMID: 28078009 Free PMC article.

4

HIF-1α inhibits IDH-1 expression in osteosarcoma.

Liu DC, Zheng X, Zho Y, Yi WR, Li ZH, Hu X, Yu AX. Liu DC, et al. Oncol Rep. 2017 Jul;38(1):336-342. doi: 10.3892/or.2017.5655. Epub 2017 May 22. Oncol Rep. 2017. PMID: 28534992

5

Comparative effectiveness study between negative pressure wound therapy and conventional wound dressing on perforator flap at the Chinese tertiary referral teaching hospital.

Mendame Ehya RE, Zhao Y, Zheng X, Yi W, Bounda GA, Li Z, Xiao W, Yu A. Mendame Ehya RE, et al. Among authors: yi w. J Tissue Viability. 2017 Nov;26(4):282-288. doi: 10.1016/j.jtv.2017.07.002. Epub 2017 Jul 12. J Tissue Viability. 2017. PMID: 28734659

6

A NIR-II fluorescent probe for articular cartilage degeneration imaging and osteoarthritis detection.

Yi W , Zhou H , Li A , Yuan Y , Guo Y , Li P , Qi B , Xiao Y , Yu A , Hu X . Yi W , et al. Biomater Sci. 2019 Feb 26;7(3):1043-1051. doi: 10.1039/c8bm01440j. Biomater Sci. 2019. PMID: 30628591

7

NIR-II Fluorescence Imaging of Skin Avulsion and Necrosis.

Li Y, Hu X, Yi W, Li D, Guo Y, Qi B, Yu A. Li Y, et al. Among authors: yi w. Front Chem. 2019 Oct 22;7:696. doi: 10.3389/fchem.2019.00696. eCollection 2019. Front Chem. 2019. PMID: 31696110 Free PMC article.

8

The Optimal Outcome of Suppressing Ewing Sarcoma Growth in vivo With Biocompatible Bioengineered miR-34a-5p Prodrug.

Li DF, Yuan Y, Tu MJ, Hu X, Li YZ, Yi WR, Li PC, Zhao Y, Cheng Z, Yu AM, Jian C, Yu AX. Li DF, et al. Front Oncol. 2020 Feb 25;10:222. doi: 10.3389/fonc.2020.00222. eCollection 2020. Front Oncol. 2020. PMID: 32161722 Free PMC article.

9

Peptide-based semiconducting polymer nanoparticles for osteosarcoma-targeted NIR-II fluorescence/NIR-I photoacoustic dual-model imaging and photothermal/photodynamic therapies.

Yuan Y, Diao S, Ni X, Zhang D, Yi W, Jian C, Hu X, Li D, Yu A, Zhou W, Fan Q. Yuan Y, et al. Among authors: yi w. J Nanobiotechnology. 2022 Jan 21;20(1):44. doi: 10.1186/s12951-022-01249-4. J Nanobiotechnology. 2022. PMID: 35062957 Free PMC article.

10

Chidamide augment sorafenib-derived anti-tumor activities in human osteosarcoma cells lines and xenograft mouse model.

Yuan Y, Li D, Hu X, Li Y, Yi W, Li P, Zhao Y, Li Z, Yu A, Jian C, Yu A. Yuan Y, et al. Among authors: yi w. Med Oncol. 2022 Apr 28;39(5):87. doi: 10.1007/s12032-022-01684-1. Med Oncol. 2022. PMID: 35478053

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,052 results

Search Page